News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
Presentation THT 2023 Why Invasive Cardiopulmonary Exercise Testing; What is the Added Value? Presenter: Greg Lewis March 21, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Daily News More Hints That Cardiac Abnormalities Resolve Fully After MIS-C Shelley Wood January 16, 2023
News Daily News Cardiopulmonary Tests in Long COVID Offer Some Clues, Pose More Questions L.A. McKeown October 21, 2022
News Daily News Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry Todd Neale May 20, 2022
News Conference News ACC 2022 METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF Todd Neale April 08, 2022
News Daily News Cardiopulmonary Tests Urged for Lasting Fatigue, Dyspnea After COVID-19 Todd Neale December 02, 2021
News Conference News ESC Heart Failure 2021 Beta-blocker Withdrawal Boosts Peak VO2 in HFpEF Subset: PRESERVE-HR Shelley Wood July 06, 2021
News Conference News AHA 2020 Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF Todd Neale November 16, 2020
News Daily News Pulmonary Hypertension During Exercise Foretells Later Risk of Adverse CV Outcomes Caitlin E. Cox January 07, 2020
News Industry News Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure February 25, 2019